From: The airway neuro-immune axis as a therapeutic target in allergic airway diseases
Airway nerves | Targeted cells | The impact on allergy airway diseases | Refs |
---|---|---|---|
Sympathetic nerves | Allergic asthma | ||
Airway smooth muscle cells | Bronchodilation | ||
ILC2 | Reduce type 2 cytokine and attenuate lung inflammation | [31] | |
Allergic rhinitis | |||
Vascular smooth muscle cell | Vasoconstriction | [57] | |
Parasympathetic nerves | Allergic asthma | ||
Airway smooth muscle cells | Bronchoconstriction/bronchodilation | ||
Epithelial cells, Macrophages, Eosinophils | Mucus secretion Inhibit airway hyperresponsiveness and airway inflammation Upregulate IL-5 and IL-13, promotes the accumulation of eosinophils | ||
ILC2s | Reduce pro-inflammatory cytokines production | ||
Allergic rhinitis | |||
Eosinophils, Lymphocytes | Recruit eosinophils | [64] | |
Vascular smooth muscle cell | Vasodilation | [65] | |
Sensory nerves and neuroendocrine cells | Allergic asthma | ||
Smooth muscle cell | Bronchoconstriction, vasodilation, and increased mucus secretion | [47] | |
Allergic rhinitis | |||
Vasodilation in the nasal mucosa, plasma extravasation, and glandular secretion | |||
Allergic asthma | |||
Mast cell, ILC2s, Eosinophils, Monocytes Dendritic cells, Macrophages, | Release pro-inflammatory cytokines, chemokines, and recruit immune cells Affect the antigen presentation function of DCs | ||
Allergic rhinitis | |||
Neutrophils | Release pro-inflammatory cytokines, chemokines, and recruit immune cells | [68] |